Edition:
United Kingdom

Qiagen NV (QGEN.N)

QGEN.N on New York Stock Exchange

38.30USD
9:02pm BST
Change (% chg)

$-0.23 (-0.60%)
Prev Close
$38.53
Open
$38.58
Day's High
$38.68
Day's Low
$37.97
Volume
801,135
Avg. Vol
334,094
52-wk High
$41.52
52-wk Low
$31.95

Latest Key Developments (Source: Significant Developments)

Qiagen Acquires U.S. Molecular Decision Support N-Of-One Company
Monday, 7 Jan 2019 

Jan 7 (Reuters) - Qiagen NV ::QIAGEN ACQUIRES N-OF-ONE, EXPANDING ITS CLINICAL BIOINFORMATICS CAPABILITIES IN MOLECULAR ONCOLOGY DECISION SUPPORT.ACQUIRE N-OF-ONE, INC., A PRIVATELY-HELD U.S. MOLECULAR DECISION SUPPORT COMPANY.N-OF-ONE'S TECHNOLOGY-ENABLED, YET HUMAN-DRIVEN, SERVICES AND PROPRIETARY MARKERMINE™ DATABASE ARE PLANNED TO BE INTEGRATED INTO QIAGEN CLINICAL INSIGHT (QCI).  Full Article

Qiagen Announces New Collaboration With Novartis
Thursday, 6 Dec 2018 

Dec 6 (Reuters) - Qiagen NV ::QIAGEN ANNOUNCES NEW COLLABORATION TO DEVELOP COMPANION DIAGNOSTIC TO GUIDE TREATMENT FOR PATIENTS WITH PIK3CA-MUTATED ADVANCED BREAST CANCER.QIAGEN - TO COLLABORATE WITH NOVARTIS TO DEVELOP COMPANION DIAGNOSTIC TO GUIDE TREATMENT FOR PATIENTS WITH PIK3CA-MUTATED ADVANCED BREAST CANCER.  Full Article

Blocktrade - Qiagen Bookrunner Says Deal Upsized To $500 Mln On Convertible Notes
Tuesday, 6 Nov 2018 

Nov 6 (Reuters) - Qiagen's Bookrunner::BLOCKTRADE - QIAGEN: BOOKRUNNER SAYS DEAL UPSIZED TO $500M; BOOKS TO CLOSE AT 13.30 UK.  Full Article

Qiagen Convertible Notes Bookrunner Says Orders Below 1 Pct Coupon & 27.5 Pct Premium Risk Missing
Tuesday, 6 Nov 2018 

Nov 6 (Reuters) - Qiagen's Bookrunner Says::BLOCKTRADE - QIAGEN: BOOKRUNNER SAYS ORDERS BELOW 1.00 PERCENT COUPON AND 27.5 PERCENT PREMIUM RISK MISSING; BOOKS CLOSE AT 12:30PM UKT.  Full Article

Qiagen Bookrunner Says Books Are Covered On Convertible Notes
Tuesday, 6 Nov 2018 

Nov 6 (Reuters) - Qiagen NV's Bookrunner::BLOCKTRADE - QIAGEN: BOOKRUNNER SAYS BOOKS ARE COVERED, FURTHER GUIDANCE TO FOLLOW.  Full Article

Qiagen Announces Convertible Notes Offer
Tuesday, 6 Nov 2018 

Nov 6 (Reuters) - Qiagen NV ::SAYS LAUNCHES NON-US OFFERING OF CASH SETTLED CONVERTIBLE NOTES COMBINED WITH CONVERTIBLE NOTE HEDGE AND WARRANT TRANSACTIONS.INTENDS TO PLACE NOTES IN AN AGGREGATE VOLUME OF $400 MILLION.NUMBER OF ORDINARY SHARES OF QIAGEN UNDERLYING NOTES WILL BE UP TO 8.5 MILLION, REPRESENTING APPROXIMATELY 3.8% OF CURRENT OUTSTANDING SHARES.INTENDS TO USE PROCEEDS FROM ISSUANCE OF NOTES FOR GENERAL CORPORATE PURPOSES.NOTES WILL HAVE A MATURITY OF 6 YEARS, WILL BE ISSUED AND REDEEMED AT 100% OF THEIR PRINCIPAL AMOUNT, PAY A COUPON BETWEEN 0.75% - 1.25% P. A..INITIAL CONVERSION PRICE WILL BE SET AT A CONVERSION PREMIUM OF 27.5%.  Full Article

Diasorin Launches New Liaison Quantiferon-TB Gold Plus In Partnership With Qiagen
Monday, 17 Sep 2018 

Sept 17 (Reuters) - Diasorin Spa ::LAUNCHES NEW LIAISON QUANTIFERON-TB GOLD PLUS ASSAY AS AN AID FOR LATENT TUBERCULOSIS DETECTION IN PARTNERSHIP WITH QIAGEN.SAYS TEST WAS DEVELOPED IN A PARTNERSHIP BETWEEN DIASORIN AND QIAGEN.SAYS TEST WILL BE LAUNCHED IN U.S. BY 2019 AND IN CHINA BY 2020.  Full Article

Qiagen to conduct an up to $200 mln share repurchase program
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Qiagen Nv ::DGAP-ADHOC: QIAGEN N.V.: QIAGEN TO CONDUCT AN UP TO US$200 MILLION SHARE REPURCHASE PROGRAM.‍REPURCHASE PROGRAM IS SCHEDULED TO BEGIN AT EARLIEST ON FEBRUARY 6, 2018, AND TO BE COMPLETED ON DECEMBER 21, 2018, AT LATEST​.  Full Article

Qiagen to exceed $140 mln of NGS-related sales In 2018
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Qiagen Nv ::SAYS ‍GOAL SET TO EXCEED $140 MILLION OF NGS-RELATED SALES IN 2018, UP FROM OVER $115 MILLION IN 2017​.  Full Article

Qiagen, DiaSorin partner in automated tuberculosis detection
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Qiagen Nv ::SAYS ‍QIAGEN AND DIASORIN PARTNER TO OFFER FULLY AUTOMATED TUBERCULOSIS DETECTION WITH QUANTIFERON-TB GOLD PLUS AVAILABLE ON LIAISON ANALYZER SYSTEMS​.SAYS ‍DIASORIN TO ADD NOVEL CONTENT TO ALREADY BROAD LIAISON MENU, OVER 7,000 SYSTEMS INSTALLED​.SAYS ‍ANNOUNCES MILESTONE OF OVER 40 MILLION QUANTIFERON-TB TESTS SINCE LAUNCH​.  Full Article

German stocks - Factors to watch on April 15

BERLIN/FRANKFURT, April 15 The following are some of the factors that may move German stocks on Monday: